IOMAI CORPORATION
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global ... vaccine market. The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.
IOMAI CORPORATION
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.iomai.com
Total Employee:
51+
Status:
Active
Contact:
(301)556-4500
Total Funding:
54 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS
Current Advisors List
Current Employees Featured
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Iomai Corporation
China Development Industrial Bank (CDIB)
China Development Industrial Bank (CDIB) investment in Series C - Iomai Corporation
Domain Associates
Domain Associates investment in Series C - Iomai Corporation
Technology Partners
Technology Partners investment in Series C - Iomai Corporation
MedImmune Ventures
MedImmune Ventures investment in Series C - Iomai Corporation
SAM Private Equity
SAM Private Equity investment in Series C - Iomai Corporation
ProQuest Investments
ProQuest Investments investment in Series C - Iomai Corporation
New Enterprise Associates
New Enterprise Associates investment in Series C - Iomai Corporation
Official Site Inspections
http://www.iomai.com
- Host name: 104.21.28.20
- IP address: 104.21.28.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Iomai Corporation"
IOMAI - Wikipedia
IOMAI was a Biotech company founded in 1997 by Gregory Glenn M.D. of the Walter Reed Army Institute of Research and Dean Lewis, a World Bank employee. The company was the first to develop the concept of transcutaneous immunization, delivery of vaccines to the skin using a patch or similar method. This provided a means to stimulate robust immune responses safely as the skin patch-based immunization targeted Langerhans cells in the skin. The patch technology …See details»
Iomai Corporation - Crunchbase Company Profile
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called …See details»
Iomai 2025 Company Profile: Valuation, Investors, Acquisition
Iomai General Information Description. Developer of vaccines and immune system stimulants. The company is focused on discovering and developing vaccines and immune system …See details»
Iomai Corporation Management Team | Org Chart - RocketReach
The Iomai Corporation management team includes Richard Kenney (Vice President, Clinical Development), Gregory Glenn (Chief Scientific Officer), and Julia Chung (Dir, Data …See details»
Iomai Corporation - Contacts, Employees, Board Members
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called. New. Resources. ... Log In. Experience the new …See details»
Iomai Corporation : Shareholders Board Members Managers and …
Iomai Corporation : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»
IOMAI CORP Company Profile | Gaithersburg, MD - Dun
Find company research, competitor information, contact details & financial data for IOMAI CORP of Gaithersburg, MD. Get the latest business insights from Dun & Bradstreet.See details»
Iomai - VentureRadar
Vaccines and immune system stimulants delivered through novel needle-free transcutaneous immunization ... Find out more about Iomai, Healthcare, Biopharma and Healthtech and Life …See details»
Iomai Corporation - 2025 Company Profile - Tracxn
Mar 20, 2025 Iomai Corporation is an acquired company based in Gaithersburg (United States), founded in 1997. It operates as a Vaccine and Immune system stimulants. Iomai Corporation …See details»
Iomai Corp. - nsti.org
Iomai Corp. 20 Firstfield Rd Ste 250 Gaithersburg, Maryland United States 301-556-4500 www.iomai.com. Nanotechnology Company Directory . To add your company, or to update …See details»
Intercell - Overview, News & Similar companies | ZoomInfo.com
Intercell contact info: Phone number: (301) 556-4500 Website: www.iomai.com What does Intercell do? Intercell AG was a biotechnology company based in Vienna which focused on the …See details»
Intercell AG to Acquire Iomai Corporation to Expand Late Stage …
May 12, 2008 Under the terms of the merger agreement, Intercell will acquire Iomai for USD 6.60 per share of Iomai's common stock representing a fully diluted equity value of Iomai of …See details»
Iomai Corporation - VentureRadar
Similar Companies: ROX Medical USA Privately Held ROX Medical is a privately held medical device company pioneering an innovative interventional vascular device therapy for …See details»
Iomai Corporation - Funding, Financials, Valuation & Investors
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology calledSee details»
Working At Iomai Corporation: Company Overview and Culture
Learn about working at Iomai Corporation from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. Find out what it's like to work at …See details»
Iomai Corporation Company Overview, Contact Details
Iomai Corporation 's official website is iomai.com and has social profiles on LinkedIn. What is Iomai Corporation 's SIC code NAICS code? Iomai Corporation 's SIC code is 8733 - …See details»
Intercell AG to acquire Iomai Corporation to expand late stage …
May 12, 2008 Intercell AG to acquire Iomai Corporation to expand late stage porduct pipeline & strengthen leadership in vaccine innovation » Intercell AG (“Intercell”) to acquire Iomai …See details»
Evolving OpenAI’s structure
5 days ago An update from the OpenAI board on transitioning its for-profit entity to a Public Benefit Corporation, reinforcing its mission-driven structure under nonprofit oversight while …See details»
Iomai Corporation - Crunchbase
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology calledSee details»
Iomai Corporation - Tech Stack, Apps, Patents & Trademarks
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called. New. Resources. Advanced Search. Start Free Trial . …See details»